Global Autoimmune Treatment Market– Industry Trends and Forecast to 2025

  • Healthcare IT
  • Upcoming Report
  • Aug 2018
  • Global
  • 350 Pages
  • No of Tables: 60
  • No of Figures: 220

Global Autoimmune Treatment Market, By Product (Diagnostic Equipment’s, Drugs, Therapeutic & Monitoring Equipment’s), Application type {Autoimmune Disease (Rheumatoid Arthritis, Psoriasis, Lupus, Others), Systemic Diseases}, Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa)– Industry Trends and Forecast to 2025

Market Analysis: Global Autoimmune Treatment Market

The Global Autoimmune Treatment Market is expected to reach USD 50.92 billion by 2025, from USD 37.79 billion in 2017 growing at a CAGR of 3.8% during the forecast period of 2018 to 2025. The upcoming market report contains data for historic year2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.

Market Definition: Global Autoimmune Treatment Market

An autoimmune disorder is the disorder which occurs when the body’s immune system is unable to differentiate between own cells and foreign cells due to which body mistakenly attacks normal cells. The symptoms of this disorder include abdominal pain, recurring fever, swollen glands, fatigue, and joint pain, swelling and skin problems. Increased prevalence rate of autoimmune disorder leads to substantial growth in global autoimmune treatment market. For instance, according to The National Institutes of Health (NIH), it was estimated that up to 23.5 million of Americans have an autoimmune disorder in comparison, to cancer which affects up to 9 million and heart disease up to 22 million. There have been tremendous technological advancements in the field of autoimmune disorder in the last decade. For instance, phospho-specific flow cytometry technology enables the simultaneous and high-throughput examination of several phosphoepitopes within multiple cell populations, such as distinct immune compartments in the spleen or blood. This approach can facilitate a broad range of novel studies aimed at deciphering intracellular signaling events within heterogeneous populations of primary cells.

Major Market Drivers and Restraints:

  • Novel biomarkers for autoimmune diagnosis
  • Rising technological advancements
  • Rising product approval and launches
  • Portable diagnostic equipments

Market Segmentation: Global Autoimmune Treatment Market

  • The global autoimmune treatment market is segmented based on product type, application type, and geographical segments.
  • Based on product type, the market is segmented into diagnostic equipment’s, drugs, therapeutic & monitoring equipment’s.
  • On the basis of application type, the market is segmented into autoimmune disease and systemic disease. Autoimmune disease market is further segmented into rheumatoid arthritis, psoriasis, lupus, others
  • Based on geography, the market report covers data points for 28 countries across multiple geographies namely North America & South America, Europe, Asia-Pacific and, Middle East & Africa. Some of the major countries covered in this report are U.S., Canada, Germany, France, U.K., Netherlands, Switzerland, Turkey, Russia, China, India, South Korea, Japan, Australia, Singapore, Saudi Arabia, South Africa and, Brazil among others

Key Developments in the Market: 

  • Abbott (U.S) and Reata Pharmaceuticals (U.S) have entered into a worldwide collaboration to develop and commercialize Reata's portfolio of second-generation oral antioxidant inflammation modulators (AIMs). The agreement is in addition to the partnership between the two companies announced in September 2010 in which Reata granted to Abbott exclusive rights to develop and commercialize its lead AIM compound, bardoxolone methyl, outside of the United States, excluding certain Asian markets.
  • Dec, 2017 The U.S. Food and Drug Administration approved use of Nucala (mepolizumab) to treat adult patients with eosinophilic granulomatosis with polyangiitis (EGPA), a rare autoimmune disease that causes vasculitis, an inflammation in the wall of blood vessels of the body

Competitive Analysis: Global Autoimmune Treatment Market

The global autoimmune treatment market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes global autoimmune treatment market for global, Europe, North America, Asia Pacific and South America

 Major Market Competitors/Players: Global Autoimmune Treatment Market

Some of the major players operating in the global autoimmune treatment market are Abbott Laboratories, Amgen Inc., Genentech Inc., F. Hoffmann-La Roche AG, Merck & Co. Inc., Bayer Schering Pharma AG, Johnson & Johnson Inc., Biogen Idec Inc., GlaxoSmithKline Plc, Squibb Company, Elan Corporation Plc, Eli Lilly and Company, Chugai Pharmaceutical Co. Ltd., Thermo Fisher Scientific, Bio-Rad Laboratories, Siemens Healthcare Amgen, Pfizer, Roche, Astrazeneca Plc and Bristol-Myers Squibb Co. amongst others.

Research Methodology: Global Autoimmune Treatment Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analysed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please Request an Analyst Call or can drop down your Inquiry.

Primary Respondents: Global Autoimmune Treatment Market

Demand Side:  Doctors, Medical Consultants, Nurses, Hospital Buyers, Group Purchasing Organizations, Associations, Insurers, Medical Payers, Healthcare Authorities, Universities, Technological Writers, Scientists, Promoters, and Investors among others.

Supply Side: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, Regulatory Affairs Managers among others

Reasons to Purchase this Report

  • Current and future of global autoimmune treatment market outlook in the developed and emerging markets
  • The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.
  • Regions/countries that are expected to witness the fastest growth rates during the forecast period
  • The latest developments, market shares, and strategies that are employed by the major market players

Customization of the Report

  • The report includes the complete segmentation displayed above across all above mentioned countries
  • All products covered in the market, product volume and average selling prices will be included as customizable options which may incur no or minimal additional cost (depends on customization)


Please fill in the below form for detailed Table of Content

Please fill in the below form for detailed List of Table

Please fill in the below form for detailed List of Figure

  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00
Why Choose Us